Literature DB >> 28144881

Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk.

NaNa Wang1, KeYu Chen2, Jia Xu1, Fang Yuan3, HongYu Li4, FengMei Deng5, LuShun Zhang6.   

Abstract

Evidence from recent researchers suggested that RTN4 is a multifunctional gene, including tumor suppression, apoptosis, vascular remodeling, and inhibition of axonal regeneration. The CAA and TATC insertion/deletion polymorphisms (CAA/TATC polymorphisms) of RTN4 3″-untranslated regions (UTRs) have been linked to cervical squamous cell carcinoma (CSCC), uterine leiomyomas (UL) and non-small cell lung cancer (NSCLC). However, the association between these two polymorphisms sites with Hepatocellular Carcinoma (HCC) risk was not carry out before. A total of 284 HCC patients and 484 control subjects were recruited for this study. The RTN4 CAA/TATC insertion/deletion genotypes were determined using polymerase chain reaction (PCR) assay. The ID/DD genotypes of CAA were significantly associated with an increased risk of HCC compared with the II genotype (ID vs. II: OR = 1.50, 95% CI: 1.10-2.04; DD vs. II: OR = 2.00, 95%CI: 1.15-3.46). Meanwhile, the frequency of D allele of CAA was significantly related with an increased risk of HCC compared with the I allele (D vs. I: OR = 1.39, 95% CI: 1.12-1.73). The ID genotypes of TATC was significantly associated with an increased risk of HCC compared with the DD genotype (ID vs. DD: OR = 1.70, 95% CI: 1.23-2.33). The present study provided evidence that RTN4 CAA/TATC polymorphisms were associated with HCC development in Chinese Han population.

Entities:  

Keywords:  Hepatocellular carcinoma; Nogo; Polymorphisms; RTN4

Mesh:

Substances:

Year:  2017        PMID: 28144881     DOI: 10.1007/s12253-017-0204-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

Review 1.  The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

Authors:  B Conne; A Stutz; J D Vassalli
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 2.  Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.

Authors:  Zdenko Herceg; Anupam Paliwal
Journal:  Mutat Res       Date:  2011-04-15       Impact factor: 2.433

3.  Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Kazuaki Nakanishi; Michiie Sakamoto; Susumu Yamasaki; Satoru Todo; Setsuo Hirohashi
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

4.  Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer.

Authors:  Q Li; B Qi; K Oka; M Shimakage; N Yoshioka; H Inoue; A Hakura; K Kodama; E J Stanbridge; M Yutsudo
Journal:  Oncogene       Date:  2001-07-05       Impact factor: 9.867

5.  The effect of alcohol on Sirt1 expression and function in animal and human models of hepatocellular carcinoma (HCC).

Authors:  Kyle J Thompson; John R Humphries; David J Niemeyer; David Sindram; Iain H McKillop
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice.

Authors:  Keitaro Tashiro; Ayano Satoh; Teruo Utsumi; Chuhan Chung; Yasuko Iwakiri
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

7.  Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.

Authors:  Kui Zhang; Peng Bai; Shaoqing Shi; Bin Zhou; Yanyun Wang; Yaping Song; Li Rao; Lin Zhang
Journal:  Pathol Oncol Res       Date:  2013-03-12       Impact factor: 3.201

8.  Nogo-A inhibits necdin-accelerated neurite outgrowth by retaining necdin in the cytoplasm.

Authors:  Xiujie Liu; Yonggang Wang; Yong Zhang; Wei Zhu; Xiaohui Xu; Michio Niinobe; Kazuaki Yoshikawa; Changlin Lu; Cheng He
Journal:  Mol Cell Neurosci       Date:  2009-02-06       Impact factor: 4.314

9.  The association between dilated cardiomyopathy and RTN4 3'UTR insertion/deletion polymorphisms.

Authors:  Bin Zhou; Li Rao; Yi Li; Linbo Gao; Cui Li; Yu Chen; Hui Xue; Weibo Liang; Meili Lv; Yaping Song; Ying Peng; Lin Zhang
Journal:  Clin Chim Acta       Date:  2008-10-08       Impact factor: 3.786

10.  Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.

Authors:  Li-Na Mu; Wei Cao; Zuo-Feng Zhang; Lin Cai; Qing-Wu Jiang; Nai-Chieh You; Binh Yang Goldstein; Guo-Rong Wei; Chuan-Wei Chen; Qing-Yi Lu; Xue-Fu Zhou; Bao-Guo Ding; Jun Chang; Shun-Zhang Yu
Journal:  Cancer Causes Control       Date:  2007-05-15       Impact factor: 2.506

View more
  1 in total

1.  Circular RNA hsa_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p.

Authors:  Hao Shen; Haifeng Li; Jiahua Zhou
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.